B BRAUN L6121 DEXTROSE & SODIUM CHLORIDE INJECTIONS 500mL 5% Dextrose & 0.45% Sodium Chloride Injection (Rx), 24/cs (40 cs/plt) (Short-Dated, Minimum Expiry Lead is 60 days
B BRAUN L6121 DEXTROSE & SODIUM CHLORIDE INJECTIONS 500mL 5% Dextrose & 0.45% Sodium Chloride Injection (Rx), 24/cs (40 cs/plt) (Short-Dated, Minimum Expiry Lead is 60 days
• Model: L6121
• Strength / Composition: 5 % dextrose
• Volume / Container: 500 mL
• 24 Bags/ Case
• 40 Cases/ Pallet
The B. Braun L6121 5% Dextrose & 0.45% Sodium Chloride Injection in the 500 mL size offers a balanced intravenous solution combining carbohydrate calories (via dextrose) with moderate sodium and chloride content. This makes it well‑suited for patients who require not only hydration but also some caloric input—particularly in instances where oral intake is limited. Because the sodium and chloride concentrations are lower than full isotonic saline, this solution provides fluid maintenance with added substrate while reducing the risk of sodium overload in certain settings.
The EXCEL® container adds a layer of convenience and patient‑safety design: flexible plastic (PVC‑ and DEHP‑free) and latex‑free, the bag supports additive compatibility and reduces concerns of plasticizer leachables or latex sensitization. The single‑use bag format simplifies workflow for infusion setup, and the absence of antimicrobial preservatives means the solution can be used with added medications (per aseptic technique) if indicated. These design factors make it particularly attractive for inpatient settings, pediatric units, or facilities with heightened material safety protocols.
From an operational perspective, the 500 mL size and 24‑bag case pack support efficient stocking in clinical units where moderate volumes of IV fluids are used daily. Having a solution with both hydration and calorie content enables facilities to standardize on fewer product types without sacrificing clinical flexibility. The fact that the solution is indicated for both adults and pediatrics adds inventory simplicity. Overall, this product offers a well‑balanced IV fluid option that addresses hydration, energy provision, and material‑safety concerns in one reusable workflow framework.
EXCEL containers, available in 250 mL, 500 mL and 1 liter sizes, are made from a multilayered film specifically developed for parenteral therapy. The film contains no plasticizers and exhibits virtually no leachability. The solution contact layer is a rubberized copolymer of ethylene and propylene. The containers are crystal clear; nontoxic and biologically inert. 5% Dextrose and 0.45% Sodium Chloride.
B BRAUN L6121 DEXTROSE & SODIUM CHLORIDE INJECTIONS 500mL 5% Dextrose & 0.45% Sodium Chloride Injection (Rx), 24/cs (40 cs/plt) (Short-Dated, Minimum Expiry Lead is 60 days
• Model: L6121
• Strength / Composition: 5 % dextrose
• Volume / Container: 500 mL
• 24 Bags/ Case
• 40 Cases/ Pallet
The B. Braun L6121 5% Dextrose & 0.45% Sodium Chloride Injection in the 500 mL size offers a balanced intravenous solution combining carbohydrate calories (via dextrose) with moderate sodium and chloride content. This makes it well‑suited for patients who require not only hydration but also some caloric input—particularly in instances where oral intake is limited. Because the sodium and chloride concentrations are lower than full isotonic saline, this solution provides fluid maintenance with added substrate while reducing the risk of sodium overload in certain settings.
The EXCEL® container adds a layer of convenience and patient‑safety design: flexible plastic (PVC‑ and DEHP‑free) and latex‑free, the bag supports additive compatibility and reduces concerns of plasticizer leachables or latex sensitization. The single‑use bag format simplifies workflow for infusion setup, and the absence of antimicrobial preservatives means the solution can be used with added medications (per aseptic technique) if indicated. These design factors make it particularly attractive for inpatient settings, pediatric units, or facilities with heightened material safety protocols.
From an operational perspective, the 500 mL size and 24‑bag case pack support efficient stocking in clinical units where moderate volumes of IV fluids are used daily. Having a solution with both hydration and calorie content enables facilities to standardize on fewer product types without sacrificing clinical flexibility. The fact that the solution is indicated for both adults and pediatrics adds inventory simplicity. Overall, this product offers a well‑balanced IV fluid option that addresses hydration, energy provision, and material‑safety concerns in one reusable workflow framework.
EXCEL containers, available in 250 mL, 500 mL and 1 liter sizes, are made from a multilayered film specifically developed for parenteral therapy. The film contains no plasticizers and exhibits virtually no leachability. The solution contact layer is a rubberized copolymer of ethylene and propylene. The containers are crystal clear; nontoxic and biologically inert. 5% Dextrose and 0.45% Sodium Chloride.
Description
B BRAUN L6121 DEXTROSE & SODIUM CHLORIDE INJECTIONS 500mL 5% Dextrose & 0.45% Sodium Chloride Injection (Rx), 24/cs (40 cs/plt) (Short-Dated, Minimum Expiry Lead is 60 days
• Model: L6121
• Strength / Composition: 5 % dextrose
• Volume / Container: 500 mL
• 24 Bags/ Case
• 40 Cases/ Pallet
The B. Braun L6121 5% Dextrose & 0.45% Sodium Chloride Injection in the 500 mL size offers a balanced intravenous solution combining carbohydrate calories (via dextrose) with moderate sodium and chloride content. This makes it well‑suited for patients who require not only hydration but also some caloric input—particularly in instances where oral intake is limited. Because the sodium and chloride concentrations are lower than full isotonic saline, this solution provides fluid maintenance with added substrate while reducing the risk of sodium overload in certain settings.
The EXCEL® container adds a layer of convenience and patient‑safety design: flexible plastic (PVC‑ and DEHP‑free) and latex‑free, the bag supports additive compatibility and reduces concerns of plasticizer leachables or latex sensitization. The single‑use bag format simplifies workflow for infusion setup, and the absence of antimicrobial preservatives means the solution can be used with added medications (per aseptic technique) if indicated. These design factors make it particularly attractive for inpatient settings, pediatric units, or facilities with heightened material safety protocols.
From an operational perspective, the 500 mL size and 24‑bag case pack support efficient stocking in clinical units where moderate volumes of IV fluids are used daily. Having a solution with both hydration and calorie content enables facilities to standardize on fewer product types without sacrificing clinical flexibility. The fact that the solution is indicated for both adults and pediatrics adds inventory simplicity. Overall, this product offers a well‑balanced IV fluid option that addresses hydration, energy provision, and material‑safety concerns in one reusable workflow framework.
EXCEL containers, available in 250 mL, 500 mL and 1 liter sizes, are made from a multilayered film specifically developed for parenteral therapy. The film contains no plasticizers and exhibits virtually no leachability. The solution contact layer is a rubberized copolymer of ethylene and propylene. The containers are crystal clear; nontoxic and biologically inert. 5% Dextrose and 0.45% Sodium Chloride.
